Overview
This research blend combines three peptides. BPC-157 is a synthetic gastric pentadecapeptide studied for tissue-protective and healing-related effects in animal models. TB-500 is a synthetic thymosin beta-4 fragment studied for cell migration and repair. GHK-Cu is a naturally occurring tripeptide-copper complex (glycyl-histidyl-lysine bound to copper) that has been extensively studied for skin remodeling and tissue-repair processes.
Adding GHK-Cu extends the recovery pairing toward processes such as collagen and extracellular-matrix remodeling, giving the blend a broader repair rationale. All three remain research compounds without human therapeutic approval.
Mechanism of action
Research suggests BPC-157 influences healing pathways including angiogenesis and growth-factor signaling, while TB-500 supports actin regulation and cell migration. GHK-Cu, as a copper-binding tripeptide, is studied for its role in modulating genes associated with tissue remodeling, stimulating collagen and extracellular-matrix synthesis, and delivering copper relevant to repair enzymes.
The rationale for the three-way combination is that BPC-157 and TB-500 contribute vascular and cell-migration repair mechanisms while GHK-Cu adds matrix-remodeling and copper-dependent repair activity, so the blend is presented as covering complementary stages of tissue repair. These mechanisms derive largely from animal, cell, and dermatologic research.
Research findings
BPC-157 has been studied in animal models for tissue protection and healing.,TB-500 has been studied for cell migration and angiogenesis in repair contexts.,GHK-Cu has been studied for collagen synthesis and extracellular-matrix remodeling.,Research suggests the three components address complementary aspects of repair.,GHK-Cu has a substantial dermatologic and skin-remodeling research literature.
Research context
Half-life and study parameters differ across the three components and are drawn largely from animal, cell, and dermatologic research, so combined pharmacokinetics for the blend are not well characterized. This entry summarizes the available findings at a high level only. This is a research reference only. Not approved for human use outside regulated settings; consult the primary literature.
Handling & storage
Lyophilized peptide blend is typically stored at -20 degrees Celsius for long-term laboratory storage and protected from light and moisture. Copper-containing peptides are particularly sensitive to light and oxidation and are handled accordingly. After reconstitution in a laboratory context it is generally refrigerated and used within a limited window. Avoid repeated freeze-thaw cycles.
Reported safety signals
As research compounds, the components do not have fully characterized human safety profiles, and reported effects come largely from animal and dermatologic studies. Copper-containing peptides warrant attention to copper handling in research settings. Neutral safety characterization should rely on the primary literature.
Studied alongside
This blend builds directly on the BPC-157 + TB-500 recovery pairing and is the base for the four-component repair blend that further adds KPV. It is also discussed alongside cosmetic peptides such as SNAP-8 in skin-repair research.
At a glance
Research strengths
- Adds matrix-remodeling activity to the recovery pairing.
- GHK-Cu has a deep dermatologic research literature.
- Components address complementary repair stages.
- Widely referenced in repair-focused research.
Limitations & cautions
- None of the components is approved for human therapeutic use.
- Copper-containing peptides require careful handling.
- Human clinical efficacy data are limited.
- Blend pharmacokinetics are not well characterized.
